0001209191-15-027731.txt : 20150319 0001209191-15-027731.hdr.sgml : 20150319 20150319120124 ACCESSION NUMBER: 0001209191-15-027731 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150313 FILED AS OF DATE: 20150319 DATE AS OF CHANGE: 20150319 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gevo, Inc. CENTRAL INDEX KEY: 0001392380 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 870747704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C STREET 2: Suite 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 303-858-8358 MAIL ADDRESS: STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C STREET 2: Suite 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: Gevo Inc DATE OF NAME CHANGE: 20070307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ryan Christopher Michael CENTRAL INDEX KEY: 0001512143 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35073 FILM NUMBER: 15712157 MAIL ADDRESS: STREET 1: C/O GEVO, INC., 345 INVERNESS DR. SOUTH STREET 2: BUILDING C, SUITE 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-03-13 0 0001392380 Gevo, Inc. GEVO 0001512143 Ryan Christopher Michael GEVO, INC., 345 INVERNESS DRIVE SOUTH BUILDING C, SUITE 310 ENGLEWOOD CO 80112 0 1 0 0 President and COO Common Stock 2015-03-13 4 S 0 1809 0.2436 D 327492 D Shares were sold to satisfy certain tax obligations of the reporting person triggered by the vesting of such restricted stock shares. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted May 28, 2014. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $.233 to $.2449, inclusive. The reporting person undertakes to provide to Gevo, Inc., any security holder of Gevo, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. /s/ Brett Lund, Attorney-in-fact 2015-03-13